Jeff Trewhitt
Catalyst Contributor



Jeff Trewhitt is a 23-year PhRMA veteran and two-time cancer survivor who understands at both personal and professional levels the importance of sustaining the world-leading innovation of America’s biopharmaceutical research companies. A former journalist who once covered the Food and Drug Administration, National Institutes of Health and biopharmaceutical companies, he has dealt with industry issues for more than three decades.  He is also an avid fan of Southern rock and roll, blues and progressive jazz, and attends several music festivals every year.